Hypertension Clinical Trials in Strasbourg
5 recruitingStrasbourg, France
Showing 1–5 of 5 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
AstraZeneca5,000 enrolled753 locationsNCT06742723
Recruiting
Phase 3
Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
Chronic Kidney Disease(CKD)Uncontrolled Hypertension
University Hospital, Tours720 enrolled40 locationsNCT05732727
Recruiting
A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort
Malignant Hypertension
Centre Hospitalier de PAU1,200 enrolled37 locationsNCT03755726
Recruiting
Phase 4
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Pulmonary Arterial Hypertension
AOP Orphan Pharmaceuticals AG110 enrolled19 locationsNCT06317805